CD274 and small cell lung carcinoma: In our study, we tentatively administered neoadjuvant PD-(L)1 blockade plus chemotherapy to 11 patients with LS-SCLC (i.e., group I) and administered neoadjuvant chemotherapy alone to six patients (i.e., group C) as controls.